# Sri Krishna Pharmaceuticals Limited – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited/c00c65b4-1cec-4f8b-9bdf-35d0fbd1b46a
Source feed: FDA_Inspections

> FDA inspection 1206168 of Sri Krishna Pharmaceuticals Limited, May 19, 2023. Classification: Official Action Indicated (OAI). 16 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206168
- Company Name: Sri Krishna Pharmaceuticals Limited
- Inspection Date: 2023-05-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 16

## Related Documents

- [FDA Inspection 1273929 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited/21b8f5a8-a1ed-47d8-8a0e-11f8d6d39727)
- [FDA Inspection 913677 - 2014-12-04](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited/ad2e850f-effc-4c88-8e41-c99e8c91ae15)
- FDA Inspection 757337 - 2011-11-23

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Investigator](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)

Company: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited/5afbb0e4-2595-4bfc-8ecd-7c0d9deb8b38

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c